Episode Details

Back to Episodes
Aqueous Humor and Tear Biomarkers: July 2026 Omics Updates

Aqueous Humor and Tear Biomarkers: July 2026 Omics Updates

Published 4 months, 1 week ago
Description

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/aqueous-humor-and-tear-biomarkers-july-2026-omics-updates

Test your visual field online: https://visualfieldtest.com

Support the show so new episodes keep coming: https://www.buzzsprout.com/2563091/support

Excerpt:

Introduction Glaucoma, a leading cause of irreversible vision loss, can be hard to detect early. Researchers are now looking at biomarkers in the eye’s body fluids – the aqueous humor (the fluid inside the front of the eye) and tear fluid (the film covering the eye) – to find signs of disease. New “omics” technologies (advanced protein and metabolite profiling) allow scientists to take a detailed molecular snapshot of these fluids. Recent studies (June–July 2026) have identified candidate markers in tears and aqueous humor that might help in diagnosing glaucoma or predicting its progression () (). In this update, we summarize the latest findings on tears and aqueous humor, describe how these studies were done, and discuss what it will take to turn these discoveries into real clinical tests. Tear Fluid Biomarkers Tear fluid is easy to collect (for example, by capillary tubes or filter paper), making it an attractive source of markers. Modern proteomic methods (mass spectrometry) can detect dozens of proteins in a tiny tear sample. A recent tear proteomics study of normal-tension glaucoma (a form of glaucoma with normal eye pressure) found 15 proteins that differed in patients whose visual fields were worsening (). For example, they identified the antioxidant protein peroxiredoxin-4 (PRDX4) and other proteins linked to oxidative stress. One protein, GNAI1, gave a high diagnostic score (AUC≈0.89) in distinguishing rapid progressors from slow progressors (). This suggests tear proteins may predict disease progression (prognostic use) rather than just presence of disease. Another study (in Eye Discovery, June 2026) looked across several glaucoma types and tear compositions, finding unique patterns for each subtype. These preliminary results hint that tear markers might eventually help subtype glaucoma or monitor changes, but they need confirmation. Sampling methods matter. Tears can be collected by Schirmer strips or capillary tubes, and these methods give slightly different results – for example, capillary collection is less irritating and preserves more tear proteins (). Such technical details can affect reproducibility, so it’s important to standardize collection when comparing studies. Overall, tear studies show promise. They have identified candidate biomarkers (linked to oxidative stress and inflammation) () (). But most findings are so far from small groups of patients. Larger validation studies are needed before any tear test could be used in the clinic (). Aqueous Humor Biomarkers The aqueous humor is the clear fluid bathing the front of the eye. It is obtained during procedures like cataract or glaucoma surgery. Because volumes are small, each sample is precious. Recent studies have profiled its content to find glaucoma clues: Protein and EV profiling: One work used label-free proteomics to map the protein “portraits” of aqueous humor in two common glaucoma types (primary open-angle and pseudoexfoliation glaucoma) (). They found many proteins that differed by disease type. (This study is under peer review but highlights how mass spectrometry can reveal glaucoma-specific protein changes.) Exosomal miRNA: Tiny vesicles called extracellular vesicles (exosomes) carry microRNAs (miRNAs) that regulate genes. A recent pilot study sequenced miRNAs from aqueous humor–derived exosomes in two glaucoma forms. It found, for example, t

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us